ArticleBMC ophthalmology2021

Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective.

Weiyi Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.